News
Q4 2024 Earnings Conference Call April 9, 2025 8:00 AM ET. Company Participants. Frank Mathias - Chief Executive Officer Sebastien Ribault - Chi ...
You can see the future first in San Francisco. Over the past year, the talk of the town has shifted from $10 billion compute ...
Gene therapy for cystic fibrosis is advancing fast. Explore key biotech players, clinical progress, and its potential to ...
6d
Business and Financial Times on MSNAfrican leaders urged to drive innovative healthcare funding solutionsBy Edward Adjei FRIMPONG African leaders must adopt innovative strategies to attract private sector investment to boost ...
Why not all African countries should venture into vaccine business ANALYSIS | The African Union has embarked on one of its ...
5d
TipRanks on MSNOxford Biomedica reports FY24 EPS (GPB 41.75) vs. (GPB 163.11) last yearReports FY24 revenue GBP 128.8M vs. GBP 89.5M last year. Frank Mathias, CEO of OXB, commented: “2024 was a year of strong commercial progress for ...
Amid the rubble of President Donald Trump's escalating trade war, Nvidia (NASDAQ: NVDA), the semiconductor powerhouse fueling ...
Can Unity Software catalyze its valuation with a new CEO, scrapped pricing plan, and the launch of its Vector AI platform for ...
Discover how an emerging technology called tRNA therapy could become the next big thing in genetic disease treatment.
Giulio Cossu, MD, University of Manchester, discusses barriers to gene therapy research and development.
We recently published a list of 10 Stocks Under $10 that Will Triple. In this article, we are going to take a look at where ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results